Showing 1 - 6 results of 6 for search 'Niklas Hammar', query time: 0.01s Refine Results
  1. 1
    Machine-learning approach to atrial fibrillation prediction among individuals without prior cardiovascular diseases

    Machine-learning approach to atrial fibrillation prediction among individuals without prior cardiovascular diseases by Niklas Hammar, Javier Louro, Karin Modig, Shunsuke Murata, Mozhu Ding

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Prevalence of all-cause and diagnosis-specific disability pension at the time of first coronary revascularisation: a population-based Swedish cross-sectional study.

    Prevalence of all-cause and diagnosis-specific disability pension at the time of first coronary revascularisation: a population-based Swedish cross-sectional study. by Katharina Zetterström, Margaretha Voss, Kristina Alexanderson, Torbjörn Ivert, Kenneth Pehrsson, Niklas Hammar, Marjan Vaez

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Surgical removal of tonsils and risk of COVID-19: a nested case–control study using data from UK Biobank and AMORIS Cohort

    Surgical removal of tonsils and risk of COVID-19: a nested case–control study using data from UK Biobank and AMORIS Cohort by Yanping Yang, Kejia Hu, Karin Modig, Maria Feychting, Imre Janszky, Niklas Hammar, Fang Fang, Zhe Zhang, Dang Wei

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

    Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study by Jesús Medina, Kamlesh Khunti, Stéphane Pintat, Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Eric Wittbrodt, Filip Surmont

    Published 2019-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme

    Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme by Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Iichiro Shimomura, Marilia B Gomes, Mikhail Kosiborod, Stuart Pocock, Marina V Shestakova, Hungta Chen, Javier Cid-Ruzafa

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosisResearch in context

    Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkins... by Dang Wei, Anna Freydenzon, Octave Guinebretiere, Karim Zaidi, Fen Yang, Weimin Ye, Niklas Hammar, Karin Modig, Naomi R. Wray, Maria Feychting, Nadine Hamieh, Bruno Ventelou, Beranger Lekens, Laurene Gantzer, Stanley Durrleman, Allan McRae, Baptiste Couvy-Duchesne, Fang Fang, Thomas Nedelec, Stanley Durrleman, Bruno Ventelou, Thomas Nedelec, Octave Guinebretiere, Karim Zaidi, Fang Fang, Dang Wei, Fen Yang, Allan McRae, Naomi Wray, Baptiste Couvy-Duchesne, Anna Freydenzon, Lydie Tran, Evans Cheruiyot

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: